Inspira Technologies Sets Up $2 Million At-the-Market Equity Program with A.G.P.

Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an update.

On February 17, 2026, Inspira Technologies Oxy B.H.N. Ltd. entered into a sales agreement with A.G.P./Alliance Global Partners that enables the company to issue and sell up to $2,015,985 of its ordinary shares from time to time through an at-the-market offering under an effective F-3 shelf registration. The company is not obligated to sell any shares, will pay a 3% commission on gross proceeds to the sales agent, and plans to use any funds raised for general corporate purposes, including R&D, human observational studies, regulatory activities, business development, marketing and execution of its commercialization plans, providing additional financial flexibility to support its growth in respiratory medical technologies.

The structure allows Inspira to tap equity markets opportunistically, which may help fund its ongoing technology development and regulatory pathway without committing to a single large, dilutive offering. However, any future share issuances under the agreement could dilute existing shareholders, and the pace and scale of fundraising will depend on market conditions, company needs and the sales agent’s ability to place shares in compliance with Nasdaq and securities regulations.

The most recent analyst rating on (IINN) stock is a Sell with a $0.68 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Neutral.

The score is held down primarily by weak financial performance—minimal/erratic revenue, negative gross profit, ongoing net losses, and significant cash burn—implying continued dependence on external funding. Technical indicators are broadly neutral, offering limited offset, while valuation metrics provide little support due to a negative P/E and no dividend yield.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Inspira Technologies Oxy B.H.N. Ltd. is an Israel-based medical technology company focused on respiratory care solutions. The company develops systems intended to improve oxygenation and support patients with acute respiratory conditions, and is progressing through research, human observational studies, engineering development and regulatory approval processes as it advances its commercialization strategy.

Average Trading Volume: 590,523

Technical Sentiment Signal: Sell

Current Market Cap: $24.19M

See more insights into IINN stock on TipRanks’ Stock Analysis page.